Suzie Trigg guides companies through FDA regulatory matters, high-stakes supply chain transactions, and strategic growth. She leverages her unique experience to help companies negotiate and document transactions and make well-informed decisions to address their complex FDA regulatory requirements. She holds leadership positions in the firm's Healthcare and Life Sciences Practice Group, and its Food, Beverage and Restaurant Practice Group.

Suzie is a go-to lawyer for companies tackling critical supply chain challenges, having been lead outside counsel for, among others, a 7,500+ store retailer negotiating supply chain agreements for transactions valued at more than $25 billion over five years. Her recent work also includes:

Facilitating investigations and analyses of high-stakes food safety and other product concerns, including both preventive gap analyses and analyzing specific events to determine FDA regulatory obligations and to chart a long-term course of action to correct and prevent re-occurrence of the potential concerns

Preparing and implementing supplier standards and supply chain agreements for multiple global restaurant chains

Developing and negotiating commercial agreements and quality agreements for the manufacture, supply, and distribution of both branded and private label foods, cosmetics, dietary supplements, and over-the-counter drugs

Suzie helps companies lawfully market their products by reviewing the use of specific ingredients and by reviewing product claims made on labels or in advertising. Her experience in this area includes foods, dietary supplements, cosmetics, personal care products, and over-the-counter drugs. She frequently provides advice and guidance on strategies intended to reduce the risk of a demand, class action, or regulatory enforcement.

While much of her work focuses on designing strategies to minimize risk and avoid costly delays or setbacks, Suzie also helps companies thoroughly and efficiently address obstacles, such as potential FDA enforcement actions, potential product recalls, and disputes with distributors or other supply chain partners.

Given Suzie's experience, she often leads due diligence of FDA regulated companies in connection with a potential merger or acquisition and addresses issues critical to deal closure. Suzie has also conducted due diligence for potential underwriters of securities offerings by emerging pharmaceutical, medical device, and biologic companies.

Suzie is in her third year of serving on FDLI's Food Advertising and Litigation Conference Planning Committee. She previously served on FDLI's Food and Dietary Supplements Committee and FDLI's Writing Awards Committee.

Bar Admissions
Texas, 2006

Education
J.D., University of Texas at Austin School of Law, 2006, with honors, Texas Environmental Law Journal
B.S., Animal Science, Texas A&M University, 2003

• FDA Increase Supplies in Response to COVID-19

  By Suzanne Trigg |March 2020

• FDA Warns Consumers About Unauthorized Fraudulent COVID19 Products

  By Suzanne Trigg |March 2020

• FDA Revised Guidance on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic

  By Suzanne Trigg |March 2020

Haynes and Boone Blogs

Haynes and Boone, LLP

Haynes and Boone Blogs includes the Firm Blog, IP Beacon: Patent Law Review, Practical Benefits Lawyer, Texas Insurance Academy and The Dec Sheet-Insurance Law